LicianPro

Lycia Therapeutics, Inc. ·

LYCA 8-K 2026-10-26

Lycia Therapeutics, Inc. (LYCA) 8-K dated 2026-10-26 — accession 0001628280-26-067312.

Lycia Therapeutics, Inc. (LYCA) common stock.

Lycia Therapeutics, Inc. filed a 8-K on 2026-10-26. Accession 0001628280-26-067312.

This 8-K covers: Bylaws or fiscal year change (Item 5.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for LYCA is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The LYCA SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr